VPIM
Vanguard Personalized Indexing Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
9,902
+1,804
| +22% | +$395K | 0.02% | 542 |
|
|
2025
Q1 | $1.81M | Sell |
8,098
-2,734
| -25% | -$612K | 0.03% | 525 |
|
|
2024
Q4 | $3.55M | Buy |
10,832
+2,906
| +37% | +$952K | 0.05% | 310 |
|
|
2024
Q3 | $2.38M | Sell |
7,926
-3,876
| -33% | -$1.16M | 0.04% | 415 |
|
|
2024
Q2 | $3.86M | Sell |
11,802
-114
| -1% | -$37.2K | 0.07% | 234 |
|
|
2024
Q1 | $4.72M | Buy |
11,916
+278
| +2% | +$110K | 0.1% | 181 |
|
|
2023
Q4 | $4.1M | Buy |
11,638
+698
| +6% | +$246K | 0.11% | 174 |
|
|
2023
Q3 | $4.1M | Buy |
10,940
+657
| +6% | +$247K | 0.12% | 146 |
|
|
2023
Q2 | $3.93M | Buy |
10,283
+320
| +3% | +$122K | 0.12% | 148 |
|
|
2023
Q1 | $3.45M | Buy |
9,963
+1,058
| +12% | +$367K | 0.12% | 159 |
|
|
2022
Q4 | $2.1M | Buy |
8,905
+537
| +6% | +$126K | 0.09% | 253 |
|
|
2022
Q3 | $2.06M | Sell |
8,368
-68
| -0.8% | -$16.7K | 0.09% | 219 |
|
|
2022
Q2 | $2.55M | Buy |
8,436
+632
| +8% | +$191K | 0.12% | 164 |
|
|
2022
Q1 | $3.21M | Buy |
7,804
+1,091
| +16% | +$448K | 0.16% | 110 |
|
|
2021
Q4 | $3.15M | Buy |
6,713
+5,119
| +321% | +$2.4M | 0.19% | 96 |
|
|
2021
Q3 | $677K | Buy |
1,594
+317
| +25% | +$135K | 0.06% | 366 |
|
|
2021
Q2 | $459K | Buy |
1,277
+481
| +60% | +$173K | 0.05% | 524 |
|
|
2021
Q1 | $224K | Buy |
796
+61
| +8% | +$17.2K | 0.03% | 631 |
|
|
2020
Q4 | $208K | Buy |
+735
| New | +$208K | 0.05% | 497 |
|